Protecting a blockbuster diabetes treatment for AstraZeneca
AstraZeneca AB
Major victories across IP venues for Volkswagen, Audi, Bentley, and Lamborghini
Audi AG; Audi of America, LLC; Automobili Lamborghini America, LLC; Automobili Lamborghini S.p.A.; Bentley Motors Limited; Bentley Motors, Inc; Volkswagen AG; Volkswagen Group of America, Inc.
No confusion in trademark victory on summary judgment for the American Retirement Association
American Retirement Association
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Finnegan secures favorable ITC ruling related to innovative electric SUVs for BMW
BMW of North America, LLC and Bayerische Motoren Werke AG
Finnegan fights for Sony’s “exceedingly famous” mark
Sony Group Corporation
Experience
Merck Sharp & Dohme LLC v. Hetero USA Inc., Lupin Limited et al. Merck Sharp & Dohme LLC v. Hetero USA Inc., Lupin Limited et al.
2:23-cv-00094, 2:23-cv-02364, D.N.J., Judges Cecchi, Padin, Wettre
Experience
Risen (Suzhou) Pharma Tech Co., Ltd. v. Alzheon, Inc. Risen (Suzhou) Pharma Tech Co., Ltd. v. Alzheon, Inc.
IPR2022-01200, PGR2022-00051, PTAB, Judges Newman, Snedden, Wisz
22-2232, Fed. Cir.
Experience
Sandoz Inc. v. Boehringer Ingelheim International GmbH et al. Sandoz Inc. v. Boehringer Ingelheim International GmbH et al.
PGR2022-00037, PTAB, Judges Newman, Obermann, Worth
Experience
Teva Pharmaceuticals International GmbH v. Eli Lilly and Company Teva Pharmaceuticals International GmbH v. Eli Lilly and Company
IPR2022-00738, -00739, -00796, PTAB, Judges Cotta, Wisz, Worth
1:21-cv-10954, D. Mass., Judge Burroughs
Experience
AbbVie Inc. et al v. Alvotech hf. AbbVie Inc. et al v. Alvotech hf.
1:21-cv-02258, 1:21-cv-02899, N.D. Ill., Judge Lee
Experience
Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al. Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al.
1:21-cv-01736, 1:23-cv-00554, D. Del., Judge Andrews
Experience
Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement
Eisai Co., Ltd.
Experience
Nippon Shinyaku Co., Ltd. v. Sarepta Therapeutics, Inc. Nippon Shinyaku Co., Ltd. v. Sarepta Therapeutics, Inc.
1:21-cv-01015, D. Del., Judges Hall, Williams
Experience
Certain Plant-Derived Recombinant Human Serum Albumins ("rHSA") and Products Containing Same Certain Plant-Derived Recombinant Human Serum Albumins ("rHSA") and Products Containing Same
337-TA-1238, ITC, Judge McNamara
Experience
Eli Lilly and Company v. Genentech, Inc. Eli Lilly and Company v. Genentech, Inc.
PGR2019-00043, PTAB, Judges Mitchell, Paulraj, Cotta
3:18-cv-01518, S.D. Cal., Judge Sammartino
Experience
Pfenex Inc. v. GlaxoSmithKline Biologicals SA Pfenex Inc. v. GlaxoSmithKline Biologicals SA
IPR2019-01027, -01028, PTAB
Experience
Finnegan client AbbVie secures non-institution decisions for Humira® patents Finnegan client AbbVie secures non-institution decisions for Humira® patents
IPR2018-01987, -01988, PTAB, Judges Ankenbrand, Harlow, Mitchell
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.